Pharmaceutical - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

201 to 225 of 7200 results

Top five health care trends of 2014 identified by Kalorama

Top five health care trends of 2014 identified by Kalorama

30-12-2014

Kalorama Information has identified its "Top Five Trends in Healthcare in 2014." The healthcare market…

GlobalHealthcareMergers & AcquisitionsPharmaceuticalProduction

Newron and Zambon re-submit NDA for safinamide following Refusal to File

Newron and Zambon re-submit NDA for safinamide following Refusal to File

29-12-2014

Clinical-stage biopharma company Newron and its commercial development partner, fellow Italy-based pharma…

NeurologicalNewron PharmaPharmaceuticalRegulationsafinamideUSAZambon

Roche receives Emergency Use Authorization from FDA for its LightMix Ebola Zaire rRT-PCR Test

Roche receives Emergency Use Authorization from FDA for its LightMix Ebola Zaire rRT-PCR Test

29-12-2014

Swiss drug major Roche has received Emergency Use Authorization for its LightMix Ebola Zaire rRT-PCR…

Anti-viralsPharmaceuticalRegulationRocheWest Africa

Sumitomo Dainippon to halve its Japanese production sites

Sumitomo Dainippon to halve its Japanese production sites

29-12-2014

Japanese pharma company Sumitomo Dainippon is to reduce its four production sites in Japan to just two.

Dainippon Sumitomo PharmaJapanPharmaceuticalProductionSumitomo

FDA backs Actavis’ Namzaric, but issues CRL on nebivolol/valsartan combo

FDA backs Actavis’ Namzaric, but issues CRL on nebivolol/valsartan combo

26-12-2014

The US Food and Drug Administration has approved the New Drug Application for Namzaric (formerly known…

ActavisAdamas PharmaceuticalsCardio-vasculardonepezilMemantine HCLNamzaricnebivololNeurologicalPharmaceuticalRegulationUSAvalsartan

FDA approves Teva’s Granix and Galderma’s Soolantra

FDA approves Teva’s Granix and Galderma’s Soolantra

24-12-2014

The Food and Drug Administration has approved Israeli generics giant Teva Pharmaceutical Industries’…

DermatologicalsGaldermaGranixIvermectinPharmaceuticalRare diseasesRegulationSoolantraTeva Pharmaceutcal IndustriesUSA

Novo Nordisk’s obesity drug Saxenda approved by FDA

Novo Nordisk’s obesity drug Saxenda approved by FDA

24-12-2014

Continuing its rush of year-end drug approvals, the US Food and Drug Administration late yesterday approved…

MetabolicsNovo NordiskPharmaceuticalRegulationSaxendaUSA

Reckitt Benckiser demerger goes through, creating Indivior as pharma arm

Reckitt Benckiser demerger goes through, creating Indivior as pharma arm

23-12-2014

The UK-based consumer goods giant Reckitt Benckiser Group has demerged what was once its USA-based pharma…

FinancialIndivior PLCMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserUSA

Actelion submits New Drug Application to the FDA for pulmonary arterial hypertension drug Uptravi

Actelion submits New Drug Application to the FDA for pulmonary arterial hypertension drug Uptravi

23-12-2014

Swiss biotech company Actelion has submitted a New Drug Application to the US Food and Drug Administration…

ActelionCardio-vascularPharmaceuticalRegulationselexipagSwitzerland

Vanda and Novartis to settle arbitration, with rights to Fanapt returned

23-12-2014

US biopharma firm Vanda Pharmaceuticals says it has reached a settlement agreement with Swiss drug major…

FanaptLegalLicensingMergers & AcquisitionsNeurologicalNovartisPharmaceuticalVanda Pharmaceuticals

USA files suit against Omnicare for accepting kickbacks from Abbott

23-12-2014

The United States has filed a civil False Claims Act complaint against Omnicare alleging that it solicited…

Abbott LaboratoriesDepakoteLegalMarkets & MarketingNeurologicalOmnicarePharmaceuticalUSA

Novartis' Alcon granted additional pediatric indication by the European Commission for Travatan

Novartis' Alcon granted additional pediatric indication by the European Commission for Travatan

23-12-2014

Eyecare specialist Alcon, the second-largest division of Swiss drug major Novartis, has been granted…

AlconNovartisOphthalmicsPharmaceuticalRegulationTravatanUSA

FTC puts conditions on Eli Lilly’s proposed acquisition of Novartis Animal Health

23-12-2014

US pharma major Eli Lilly has agreed to divest its Sentinel product line of medications for treating…

Eli LillyMergers & AcquisitionsNovartisPharmaceuticalUSA

Achillion shares jump on positive interim results from ACH-3102 and ACH-322 for hepatitis C

Achillion shares jump on positive interim results from ACH-3102 and ACH-322 for hepatitis C

23-12-2014

US pharma company Achillion Pharmaceuticals saw its shares jump as much as 60% on the announcement of…

ACH-3102ACH-3422Achillion PharmaceuticalsNephrology and HepatologyPharmaceuticalResearchUSA

BioCryst's Rapivab approved by FDA to treat influenza

BioCryst's Rapivab approved by FDA to treat influenza

23-12-2014

USA-based BioCryst Pharmaceuticals has received approval from the US Food and Drug Administration for…

Antibiotics and Infectious diseasesBioCryst PharmaceuticalsperamivirPharmaceuticalRegulationUSA

FDA approves Bristol-Myers Squibb’s Opdivo for advanced melanoma

FDA approves Bristol-Myers Squibb’s Opdivo for advanced melanoma

23-12-2014

The US Food and Drug Administration yesterday granted accelerated approval to US pharma major Bristol-Myers…

Bristol-Myers SquibbKeytrudaMerck & CoOncologyOpdivoPharmaceuticalRegulationUSA

China to speed up US biotech and pharma imports following trade talks

China to speed up US biotech and pharma imports following trade talks

22-12-2014

The US Commerce Secretary has said China has agreed to allow medicines and medical devices from US companies…

ChinaMarkets & MarketingPenny PritzkerPharmaceuticalUnited States

Ukraine’s new Health Minister outlines priorities at meeting with APRAD

Ukraine’s new Health Minister outlines priorities at meeting with APRAD

22-12-2014

At the instance of Association of Pharmaceutical Research and Development (APRAD), the Ministry of Health…

PharmaceuticalPoliticsPricingRegulationUkraine

Express Scripts says AbbVie’s Viekira Pak to be exclusive option for genotype 1 hepatitis C

Express Scripts says AbbVie’s Viekira Pak to be exclusive option for genotype 1 hepatitis C

22-12-2014

Express Scripts today announced an update to its National Preferred Formulary that will significantly…

AbbVieAnti-viralsExpress ScriptsGilead SciencesHarvoniPharmaceuticalPricingSovaldiUSAViekira Pak

Eli Lilly receives marketing authorization from the European Commission for Cyramza

Eli Lilly receives marketing authorization from the European Commission for Cyramza

22-12-2014

Eli Lilly has received marketing authorization from the European Commission for its drug Cyramza.

CyramzaEli LillyOncologyPharmaceuticalUSA

Roche ends Phase III trial of gantenerumab in prodromal Alzheimer’s disease

Roche ends Phase III trial of gantenerumab in prodromal Alzheimer’s disease

22-12-2014

Swiss drug major Roche is to end the Phase III study of experimental anti-amyloid drug gantenerumab in…

gantenerumabNeurologicalPharmaceuticalResearchRocheSwitzerland

Cardiome links with Eddingpharm for Brinavess in China

22-12-2014

Canadian drugmaker Cardiome Pharma has entered into an agreement with Chinese firm Eddingpharm to develop…

BrinavessCardio-vascularCardiome PharmaChinaEddingpharmLicensingPharmaceuticalTaiwan

Sussan Ley replaces Peter Dutton as Australian Minister for Health

Sussan Ley replaces Peter Dutton as Australian Minister for Health

22-12-2014

Sussan Ley has been appointed as the Australian Minister for Health, and replaces Peter Dutton.

AustraliaMinisterPharmaceuticalPoliticsSussan Ley

201 to 225 of 7200 results

Back to top